CardieX Limited (CDX.AX)
AUD 0.1
(0.0%)
AUD 0.1
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 2.74 Million AUD | 142.1% |
| 2023 | 1.39 Million AUD | 127.52% |
| 2022 | 613.87 Thousand AUD | 124.59% |
| 2021 | -2.49 Million AUD | -1529.14% |
| 2020 | 174.69 Thousand AUD | 139.0% |
| 2019 | -447.97 Thousand AUD | 82.44% |
| 2018 | -2.55 Million AUD | -276.38% |
| 2017 | -677.91 Thousand AUD | 61.78% |
| 2016 | -1.77 Million AUD | 48.58% |
| 2015 | -3.44 Million AUD | -59.12% |
| 2014 | -2.16 Million AUD | 24.57% |
| 2013 | -2.87 Million AUD | -157.24% |
| 2012 | -1.11 Million AUD | 34.82% |
| 2011 | -1.71 Million AUD | -6.58% |
| 2010 | -1.6 Million AUD | 52.92% |
| 2009 | -3.41 Million AUD | -3.02% |
| 2008 | -3.31 Million AUD | 52.62% |
| 2007 | -6.99 Million AUD | 40.74% |
| 2006 | -11.81 Million AUD | 26.86% |
| 2005 | -16.14 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 2.74 Million AUD | 23.13% |
| 2024 Q1 | 3.22 Million AUD | 130.89% |
| 2024 Q3 | 2.74 Million AUD | -18.83% |
| 2024 FY | 3.38 Million AUD | 142.1% |
| 2024 Q2 | 3.38 Million AUD | 4.92% |
| 2023 FY | 1.39 Million AUD | 127.52% |
| 2023 Q4 | 1.39 Million AUD | -58.96% |
| 2023 Q2 | 411.69 Thousand AUD | 53.74% |
| 2023 Q1 | 267.79 Thousand AUD | -56.38% |
| 2023 Q3 | 3.4 Million AUD | 726.72% |
| 2022 FY | 613.87 Thousand AUD | 124.59% |
| 2022 Q2 | -4.19 Million AUD | 1.94% |
| 2022 Q3 | 557.78 Thousand AUD | 113.31% |
| 2022 Q4 | 613.87 Thousand AUD | 10.06% |
| 2022 Q1 | -4.27 Million AUD | -71.14% |
| 2021 Q2 | -1.62 Million AUD | 6.43% |
| 2021 FY | -2.49 Million AUD | -1529.14% |
| 2021 Q4 | -2.49 Million AUD | -8.93% |
| 2021 Q3 | -2.29 Million AUD | -40.99% |
| 2021 Q1 | -1.73 Million AUD | -1094.52% |
| 2020 Q4 | 174.69 Thousand AUD | 206.52% |
| 2020 Q2 | -545.03 Thousand AUD | 16.41% |
| 2020 Q3 | 56.99 Thousand AUD | 110.46% |
| 2020 FY | 174.69 Thousand AUD | 139.0% |
| 2020 Q1 | -652.06 Thousand AUD | -45.56% |
| 2019 Q2 | -4.73 Million AUD | 0.0% |
| 2019 FY | -447.97 Thousand AUD | 82.44% |
| 2019 Q3 | -545.47 Thousand AUD | 88.48% |
| 2019 Q4 | -447.97 Thousand AUD | 17.87% |
| 2019 Q1 | -4.73 Million AUD | -85.59% |
| 2018 FY | -2.55 Million AUD | -276.38% |
| 2018 Q1 | -724.67 Thousand AUD | -6.9% |
| 2018 Q2 | -724.67 Thousand AUD | 0.0% |
| 2018 Q3 | -2.55 Million AUD | -252.09% |
| 2018 Q4 | -2.55 Million AUD | 0.0% |
| 2017 Q3 | -677.91 Thousand AUD | 61.2% |
| 2017 Q4 | -677.91 Thousand AUD | 0.0% |
| 2017 Q2 | -1.74 Million AUD | 0.0% |
| 2017 Q1 | -1.74 Million AUD | 1.51% |
| 2017 FY | -677.91 Thousand AUD | 61.78% |
| 2016 Q1 | -3.78 Million AUD | -9.7% |
| 2016 Q2 | -3.78 Million AUD | 0.0% |
| 2016 Q3 | -1.77 Million AUD | 53.13% |
| 2016 FY | -1.77 Million AUD | 48.58% |
| 2016 Q4 | -1.77 Million AUD | 0.0% |
| 2015 FY | -3.44 Million AUD | -59.12% |
| 2015 Q4 | -3.44 Million AUD | 0.0% |
| 2015 Q3 | -3.44 Million AUD | -36.99% |
| 2015 Q2 | -2.51 Million AUD | 0.0% |
| 2015 Q1 | -2.51 Million AUD | -16.15% |
| 2014 Q3 | -2.16 Million AUD | 47.15% |
| 2014 Q4 | -2.16 Million AUD | 0.0% |
| 2014 FY | -2.16 Million AUD | 24.57% |
| 2014 Q1 | -4.1 Million AUD | -42.73% |
| 2014 Q2 | -4.1 Million AUD | 0.0% |
| 2013 Q3 | -2.87 Million AUD | -34.42% |
| 2013 Q4 | -2.87 Million AUD | 0.0% |
| 2013 Q2 | -2.13 Million AUD | 0.0% |
| 2013 FY | -2.87 Million AUD | -157.24% |
| 2013 Q1 | -2.13 Million AUD | -91.37% |
| 2012 FY | -1.11 Million AUD | 34.82% |
| 2012 Q4 | -1.11 Million AUD | 0.0% |
| 2011 Q4 | -1.71 Million AUD | 0.0% |
| 2011 FY | -1.71 Million AUD | -6.58% |
| 2010 Q4 | -1.6 Million AUD | 0.0% |
| 2010 FY | -1.6 Million AUD | 52.92% |
| 2009 FY | -3.41 Million AUD | -3.02% |
| 2009 Q4 | -3.41 Million AUD | 0.0% |
| 2008 Q4 | -3.31 Million AUD | 0.0% |
| 2008 FY | -3.31 Million AUD | 52.62% |
| 2007 Q4 | -6.99 Million AUD | 0.0% |
| 2007 FY | -6.99 Million AUD | 40.74% |
| 2006 FY | -11.81 Million AUD | 26.86% |
| 2006 Q4 | -11.81 Million AUD | 0.0% |
| 2005 FY | -16.14 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 110.776% |
| Adherium Limited | -6.1 Million AUD | 144.99% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 173.291% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 176.216% |
| Anteris Technologies Ltd | -28.49 Million AUD | 109.637% |
| Control Bionics Limited | -19.02 Thousand AUD | 14537.609% |
| Compumedics Limited | 5.08 Million AUD | 46.013% |
| Cochlear Limited | -269.9 Million AUD | 101.018% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | -293.122% |
| Cyclopharm Limited | -7.49 Million AUD | 136.622% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 117.491% |
| Nova Eye Medical Limited | -2.8 Million AUD | 198.013% |
| HeraMED Limited | -799.34 Thousand AUD | 443.57% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 81.037% |
| ImpediMed Limited | -23.48 Million AUD | 111.692% |
| InhaleRx Limited | -155.54 Thousand AUD | 1865.624% |
| LBT Innovations Limited | -604 Thousand AUD | 554.689% |
| Micro-X Limited | 826.99 Thousand AUD | -232.083% |
| Neurotech International Limited | -2.11 Million AUD | 230.128% |
| OncoSil Medical Limited | -4.43 Million AUD | 161.984% |
| PolyNovo Limited | -30.52 Million AUD | 108.996% |
| Respiri Limited | 413.68 Thousand AUD | -563.861% |
| SomnoMed Limited | -15.16 Million AUD | 118.112% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 151.779% |
| Uscom Limited | -1.53 Million AUD | 279.424% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 167.263% |